Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

Extra-strength mRNA vaccine fends off a bevy of flu strains

A vaccine upgraded to target four influenza proteins instead of the usual one protects mice against a range of viral variants.
Coloured transmission electron micrograph of human cells infected with influenza virus

Human cells which are infected with the influenza virus (artificially coloured), which can be kept in check by an upgraded mRNA vaccine. Credit: Steve Gschmeissner/Science Photo Library

An experimental mRNA-based influenza vaccine induces protection against a variety of flu strains, according to studies in mice1.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Nature 611, 206 (2022)

doi: https://doi.org/10.1038/d41586-022-03525-7

References

  1. McMahon, M. et al. Proc. Natl Acad. Sci. USA 119, e2206333119 (2022).

    Article  PubMed  Google Scholar 

Download references

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links